Rekvina Labs

23
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE092O01028
  • NSEID:
  • BSEID: 526075
INR
7.43
0.35 (4.94%)
BSENSE

Jan 14

BSE+NSE Vol: 250

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'18
Mar'17
Mar'16
Mar'15
Mar'14
Mar'13
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2018 is 0.00% vs -100.00% in Mar 2017

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2018 is -108.17% vs 15.75% in Mar 2017

stock-summary

Interest

YoY Growth in year ended Mar 2018 is -6.26% vs -35.72% in Mar 2017

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2018 is -314.17% vs 65.91% in Mar 2017

Compare Profit and Loss Results of Rekvina Labs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
0.00
23,003.00
-23,003.00
-100.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
0.00
23,003.00
-23,003.00
-100.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-69.00
69.00
100.00%
Raw Materials Consumed
0.00
6,050.00
-6,050.00
-100.00%
Power & Fuel Cost
0.00
435.00
-435.00
-100.00%
Employee Cost
0.00
2,608.00
-2,608.00
-100.00%
Operating Expenses
0.00
1,261.00
-1,261.00
-100.00%
General and Administration Expenses
0.00
-1.00
1.00
100.00%
Selling and Distribution Expenses
0.00
3,149.00
-3,149.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
638.00
-638.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
0.00
16,465.00
-16,465.00
-100.00%
Operating Profit (PBDIT) excl Other Income
0.00
6,538.00
-6,538.00
-100.00%
Other Income
0.00
623.00
-623.00
-100.00%
Operating Profit (PBDIT)
0.00
7,162.00
-7,162.00
-100.00%
Interest
0.00
893.00
-893.00
-100.00%
Profit before Depriciation and Tax
0.00
6,268.00
-6,268.00
-100.00%
Depreciation
0.00
1,238.00
-1,238.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
5,030.00
-5,030.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
5,030.00
-5,030.00
-100.00%
Provision for Tax
0.00
747.00
-747.00
-100.00%
Profit After Tax
0.00
4,282.00
-4,282.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-2.00
12,731.00
-12,733.00
-100.02%
Profit Available for appropriations
-2.00
17,013.00
-17,015.00
-100.01%
Appropriations
-2.00
17,013.00
-17,015.00
-100.01%
Equity Dividend (%)
0%
1600%
-1,600.00
Earnings Per Share
-0.13
17.8
-17.93
-100.73%
Profit And Loss - Net Sales
Net Sales 0.00 Cr
in Mar 2018

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2018 is 0.00% vs -100.00% in Mar 2017

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.10 Cr
in Mar 2018

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2018 is -108.17% vs 15.75% in Mar 2017

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2018

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2018 is -6.26% vs -35.72% in Mar 2017

Profit And Loss - Profit After Tax
Profit After Tax -0.08 Cr
in Mar 2018

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2018 is -314.17% vs 65.91% in Mar 2017